Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Francica BJ"'
Autor:
Francica BJ; Tempest Therapeutics, Brisbane, California., Holtz A; Tempest Therapeutics, Brisbane, California., Lopez J; Tempest Therapeutics, Brisbane, California., Freund D; Tempest Therapeutics, Brisbane, California., Chen A; Tempest Therapeutics, Brisbane, California., Wang D; Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina., Powell D; Tempest Therapeutics, Brisbane, California., Kipper F; Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts., Panigrahy D; Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts., Dubois RN; Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina., Whiting CC; Tempest Therapeutics, Brisbane, California., Prasit P; Tempest Therapeutics, Brisbane, California., Dubensky TW; Tempest Therapeutics, Brisbane, California.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2023 Aug 08; Vol. 3 (8), pp. 1486-1500. Date of Electronic Publication: 2023 Aug 08 (Print Publication: 2023).
Autor:
Lynn GM; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA. geoffrey.lynn@avideatechnologies.com.; Avidea Technologies, Inc, Baltimore, MD, USA. geoffrey.lynn@avideatechnologies.com., Sedlik C; Institut Curie, PSL Research University, Paris, France.; Centre d'Investigation Clinique Biothérapie, Institut Curie, Paris, France., Baharom F; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Zhu Y; Avidea Technologies, Inc, Baltimore, MD, USA., Ramirez-Valdez RA; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Coble VL; Avidea Technologies, Inc, Baltimore, MD, USA., Tobin K; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Nichols SR; Avidea Technologies, Inc, Baltimore, MD, USA., Itzkowitz Y; Avidea Technologies, Inc, Baltimore, MD, USA., Zaidi N; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Gammon JM; Fischell Department of Bioengineering, University of Maryland, College Park, MD, USA., Blobel NJ; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Denizeau J; Institut Curie, PSL Research University, Paris, France.; Centre d'Investigation Clinique Biothérapie, Institut Curie, Paris, France., de la Rochere P; Institut Curie, PSL Research University, Paris, France.; Centre d'Investigation Clinique Biothérapie, Institut Curie, Paris, France., Francica BJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.; Tempest Therapeutics, San Francisco, CA, USA., Decker B; Avidea Technologies, Inc, Baltimore, MD, USA., Maciejewski M; Avidea Technologies, Inc, Baltimore, MD, USA., Cheung J; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Yamane H; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Smelkinson MG; Biological Imaging Section, Research Technologies Branch, NIAID, NIH, Bethesda, MD, USA., Francica JR; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Laga R; Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic., Bernstock JD; Avidea Technologies, Inc, Baltimore, MD, USA.; Department of Neurosurgery, Brigham and Women's Hospital, Harvard University, Boston, MA, USA., Seymour LW; Department of Oncology, University of Oxford, Oxford, UK., Drake CG; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA., Jewell CM; Fischell Department of Bioengineering, University of Maryland, College Park, MD, USA., Lantz O; Institut Curie, PSL Research University, Paris, France.; Centre d'Investigation Clinique Biothérapie, Institut Curie, Paris, France., Piaggio E; Institut Curie, PSL Research University, Paris, France.; Centre d'Investigation Clinique Biothérapie, Institut Curie, Paris, France., Ishizuka AS; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.; Avidea Technologies, Inc, Baltimore, MD, USA., Seder RA; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA. rseder@mail.nih.gov.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2020 Mar; Vol. 38 (3), pp. 320-332. Date of Electronic Publication: 2020 Jan 13.
Autor:
Sivick KE, Desbien AL, Glickman LH, Reiner GL, Corrales L, Surh NH, Hudson TE, Vu UT, Francica BJ, Banda T, Katibah GE, Kanne DB, Leong JJ, Metchette K, Bruml JR, Ndubaku CO, McKenna JM, Feng Y, Zheng L, Bender SL, Cho CY, Leong ML, van Elsas A, Dubensky TW Jr, McWhirter SM
Publikováno v:
Cell reports [Cell Rep] 2019 Oct 15; Vol. 29 (3), pp. 785-789.
Autor:
Sivick KE; Aduro Biotech, Inc., Berkeley, CA 94710, USA., Desbien AL; Aduro Biotech, Inc., Berkeley, CA 94710, USA., Glickman LH; Aduro Biotech, Inc., Berkeley, CA 94710, USA., Reiner GL; Aduro Biotech, Inc., Berkeley, CA 94710, USA., Corrales L; Aduro Biotech, Inc., Berkeley, CA 94710, USA., Surh NH; Aduro Biotech, Inc., Berkeley, CA 94710, USA., Hudson TE; Aduro Biotech, Inc., Berkeley, CA 94710, USA., Vu UT; Aduro Biotech, Inc., Berkeley, CA 94710, USA., Francica BJ; Aduro Biotech, Inc., Berkeley, CA 94710, USA., Banda T; Aduro Biotech, Inc., Berkeley, CA 94710, USA., Katibah GE; Aduro Biotech, Inc., Berkeley, CA 94710, USA., Kanne DB; Aduro Biotech, Inc., Berkeley, CA 94710, USA., Leong JJ; Aduro Biotech, Inc., Berkeley, CA 94710, USA., Metchette K; Aduro Biotech, Inc., Berkeley, CA 94710, USA., Bruml JR; Aduro Biotech, Inc., Berkeley, CA 94710, USA., Ndubaku CO; Aduro Biotech, Inc., Berkeley, CA 94710, USA., McKenna JM; Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA., Feng Y; Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA., Zheng L; Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA., Bender SL; Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA., Cho CY; Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA., Leong ML; Aduro Biotech, Inc., Berkeley, CA 94710, USA., van Elsas A; Aduro Biotech, Inc., Berkeley, CA 94710, USA., Dubensky TW Jr; Aduro Biotech, Inc., Berkeley, CA 94710, USA., McWhirter SM; Aduro Biotech, Inc., Berkeley, CA 94710, USA. Electronic address: smcwhirter@aduro.com.
Publikováno v:
Cell reports [Cell Rep] 2018 Dec 11; Vol. 25 (11), pp. 3074-3085.e5.
Autor:
Marciscano AE; Department of Radiation Oncology & Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Ghasemzadeh A; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Nirschl TR; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Theodros D; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Kochel CM; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Francica BJ; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Muroyama Y; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Anders RA; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Pathology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Sharabi AB; Department of Radiation Medicine and Applied Sciences, University of California, San Diego, Moores Cancer Center, San Diego, California., Velarde E; Department of Radiation Oncology & Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Mao W; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Chaudhary KR; Department of Radiation Oncology, Columbia University Medical Center, New York, New York., Chaimowitz MG; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York., Wong J; Department of Radiation Oncology & Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Selby MJ; Bristol-Myers Squibb Company, Redwood City, California., Thudium KB; Bristol-Myers Squibb Company, Redwood City, California., Korman AJ; Bristol-Myers Squibb Company, Redwood City, California., Ulmert D; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Thorek DLJ; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland., DeWeese TL; Department of Radiation Oncology & Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Drake CG; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. cgd2139@cumc.columbia.edu.; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Oct 15; Vol. 24 (20), pp. 5058-5071. Date of Electronic Publication: 2018 Jun 13.
Autor:
Shen YC; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Oncology, School of Medicine, National Taiwan University, Taipei, Taiwan., Ghasemzadeh A; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Medical Scientist Training Program, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY, USA., Kochel CM; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Tizona Therapeutics, South San Francisco, CA, USA., Nirschl TR; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Francica BJ; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Aduro Biotech, Berkeley, CA, USA., Lopez-Bujanda ZA; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Carrera Haro MA; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY, USA., Tam A; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Anders RA; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Selby MJ; Bristol-Myers Squibb, Redwood City, CA, USA., Korman AJ; Bristol-Myers Squibb, Redwood City, CA, USA., Drake CG; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. cgd2139@columbia.edu.; Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY, USA. cgd2139@columbia.edu.; The Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA. cgd2139@columbia.edu.; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA. cgd2139@columbia.edu.
Publikováno v:
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2018 Apr; Vol. 21 (1), pp. 113-125. Date of Electronic Publication: 2017 Dec 04.
Autor:
Francica BJ; Aduro Biotech, Berkeley, California.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland., Ghasemzadeh A; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Medicine, Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York., Desbien AL; Aduro Biotech, Berkeley, California., Theodros D; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland., Sivick KE; Aduro Biotech, Berkeley, California., Reiner GL; Aduro Biotech, Berkeley, California., Hix Glickman L; Aduro Biotech, Berkeley, California., Marciscano AE; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland., Sharabi AB; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland.; University of California San Diego School of Medicine, San Diego, California., Leong ML; Aduro Biotech, Berkeley, California., McWhirter SM; Aduro Biotech, Berkeley, California., Dubensky TW Jr; Aduro Biotech, Berkeley, California., Pardoll DM; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland., Drake CG; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland. cgd2139@cumc.columbia.edu.; Department of Medicine, Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2018 Apr; Vol. 6 (4), pp. 422-433. Date of Electronic Publication: 2018 Feb 22.
Autor:
Jackson CM; Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland., Kochel CM; Department of Oncology, Johns Hopkins University, Baltimore, Maryland., Nirschl CJ; Department of Oncology, Johns Hopkins University, Baltimore, Maryland., Durham NM; Department of Oncology, Johns Hopkins University, Baltimore, Maryland., Ruzevick J; Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland., Alme A; Department of Oncology, Johns Hopkins University, Baltimore, Maryland., Francica BJ; Department of Oncology, Johns Hopkins University, Baltimore, Maryland., Elias J; Department of Oncology, Johns Hopkins University, Baltimore, Maryland., Daniels A; Department of Oncology, Johns Hopkins University, Baltimore, Maryland., Dubensky TW Jr; Aduro Biotech, Berkeley, California., Lauer P; Aduro Biotech, Berkeley, California., Brockstedt DG; Aduro Biotech, Berkeley, California., Baxi EG; Department of Neurology, Johns Hopkins University, Baltimore, Maryland., Calabresi PA; Department of Neurology, Johns Hopkins University, Baltimore, Maryland., Taube JM; Department of Dermatology, Johns Hopkins University, Baltimore, Maryland. Department of Pathology, Johns Hopkins University, Baltimore, Maryland., Pardo CA; Department of Neurology, Johns Hopkins University, Baltimore, Maryland. Department of Pathology, Johns Hopkins University, Baltimore, Maryland., Brem H; Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland. Department of Ophthalmology, Johns Hopkins University, Baltimore, Maryland. Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland., Pardoll DM; Department of Oncology, Johns Hopkins University, Baltimore, Maryland., Lim M; Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland. cdrake@jhmi.edu mlim3@jhmi.edu., Drake CG; Department of Oncology, Johns Hopkins University, Baltimore, Maryland. Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland. cdrake@jhmi.edu mlim3@jhmi.edu.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2016 Mar 01; Vol. 22 (5), pp. 1161-72. Date of Electronic Publication: 2015 Oct 21.
Autor:
Martin AM; Department of Oncology, Johns Hopkins University, Baltimore, MD, USA., Nirschl TR; Department of Oncology, Johns Hopkins University, Baltimore, MD, USA., Nirschl CJ; Department of Oncology, Johns Hopkins University, Baltimore, MD, USA., Francica BJ; Department of Oncology, Johns Hopkins University, Baltimore, MD, USA., Kochel CM; Department of Oncology, Johns Hopkins University, Baltimore, MD, USA., van Bokhoven A; Department of Oncology, Johns Hopkins University, Baltimore, MD, USA., Meeker AK; Department of Oncology, Johns Hopkins University, Baltimore, MD, USA., Lucia MS; Department of Oncology, Johns Hopkins University, Baltimore, MD, USA., Anders RA; Department of Oncology, Johns Hopkins University, Baltimore, MD, USA., DeMarzo AM; Department of Oncology, Johns Hopkins University, Baltimore, MD, USA., Drake CG; Department of Oncology, Johns Hopkins University, Baltimore, MD, USA.
Publikováno v:
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2015 Dec; Vol. 18 (4), pp. 325-32. Date of Electronic Publication: 2015 Aug 11.
Autor:
Sharabi AB; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland. Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Nirschl CJ; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Kochel CM; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Nirschl TR; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Francica BJ; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Velarde E; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland., Deweese TL; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland. Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland. The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland., Drake CG; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland. The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland. Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland. cdrake@jhmi.edu.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2015 Apr; Vol. 3 (4), pp. 345-55. Date of Electronic Publication: 2014 Dec 19.